Webinar on Modeling impact and cost-effectiveness of HIV prevention: Presentations


Welcome, objectives, and overview
    —Yegor Voronin, Global HIV Vaccine Enterprise

Primer on simulation modeling: using model-based analyses to inform health policy and research on HIV prevention
    —Caitlin Dugdale, Massachusetts General Hospital

Modeling HIV prevention: strengths and limitations of different modeling approaches
    —Leigh Johnson, University of Cape Town

Data inputs for HIV models and how they inform HIV prevention interventions
    —Dobromir Dimitrov, Fred Hutchinson Cancer Research Center

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account